EUVIMEDEUVIMED entdecken
Crossref

Targeting the JAK-STAT pathway: Successful use of abrocitinib in refractory prurigo nodularis

Abhishek De, Apeksha Singh, Disha Chakraborty, S. K. Shahriar Ahmed

Indian Journal of Skin Allergy · 20.03.2026 · 5 · 105-106

DOI: 10.25259/ijsa_83_2025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Skin Allergy, online erschienen am 20.03.2026. Verfasst von Abhishek De und 3 weiteren Autor:innen. Die Arbeit nennt 4 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

De, A., Singh, A., Chakraborty, D., & Ahmed, S. K. S. (2026). Targeting the JAK-STAT pathway: Successful use of abrocitinib in refractory prurigo nodularis. Indian Journal of Skin Allergy, 5, 105-106. https://doi.org/10.25259/ijsa_83_2025

Vancouver

De A, Singh A, Chakraborty D, Ahmed SKS. Targeting the JAK-STAT pathway: Successful use of abrocitinib in refractory prurigo nodularis. Indian Journal of Skin Allergy. 2026;5:105-106. doi:10.25259/ijsa_83_2025

BibTeX
@article{De2026,
  author = {De, Abhishek and Singh, Apeksha and Chakraborty, Disha and Ahmed, S. K. Shahriar},
  title = {Targeting the JAK-STAT pathway: Successful use of abrocitinib in refractory prurigo nodularis},
  journal = {Indian Journal of Skin Allergy},
  year = {2026},
  volume = {5},
  pages = {105--106},
  doi = {10.25259/ijsa_83_2025}
}
Kostenlos starten →